PCR148 Patient Involvement in the Development of Outcomes Measures Specific to Neuronopathic Gaucher Disease Type 2 and Type 3 to Assess HRQoL Over the Disease Journey
Abstract
Authors
K Beusterien J Isaacs D Jaffe D Elstein M Stoodley E Haf Davies T Collin-Histed